Barcelona, 1 June 2011.- Following the announcement of the appointment of Eduardo Sanchiz as Chief Executive Officer, Almirall communicates the appointment of Daniel Martínez Carretero as Chief Financial Officer (CFO) also effective as of 1 July 2011. In addition to Finance, Daniel will also be heading the areas of Purchasing, Information Systems (IT) and Investor Relations.
Daniel Martínez brings a solid professional trajectory to this role. He has a degree in Economics and a Master's in Finance Management from EADA.
He joined Almirall in September 2008 as Deputy CFO reporting to Eduardo Sanchiz, then Director of Corporate Development and Finance. During this period Daniel Martínez has led the finance area jointly with Eduardo Sanchiz and has been responsible for various organisational and finance projects as well as being a member of the Management Board.
Prior to joining Almirall he spent several years in PepsiCo in a variety of roles in the finance area, finally holding the position of Finance Director Iberia. After PepsiCo, Daniel continued his career in Reckitt Benckiser as Finance Director for South West Europe.
About Almirall
Almirall is an international pharmaceutical company based on innovation and committed to health. Headquartered in Barcelona, Spain, it researches, develops, manufactures and commercialises its own R&D and licensed drugs with the aim of improving people’s health and wellbeing.
Almirall focuses its research resources on therapeutic areas related to the treatment of asthma, COPD (Chronic Obstructive Pulmonary Disease), gastrointestinal disorders, psoriasis and other dermatological conditions.
Almirall's products are currently present in over 70 countries while it has direct presence in Europe and Latin America through 12 affiliates.
For further information please visit the website at: www.almirall.com
More information:
Ketchum Pleon:
Sonia San Segundo / Victorino Ballestero
Tel.: 91 788 32 00
